In particular, patient #3 and patient #10 of the present cohort presenting with IgLON5 and GAD65 antibodies, respectively, fulfilled the 2004 diagnostic criteria for a definite PNS diagnosis (Table 1) [3,29,30]. This evidence concerns the gene IGLON5 and paraneoplastic neurologic syndrome.